NASDAQ:ATHA Long Term Investor Notice: Investigation of Potential Wrongdoing at Athira Pharma, Inc.
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Athira Pharma, Inc.
View full press release